Production and purification of recombinant human BLyS mutant from inclusion bodies

Protein Expression and Purification

Volumn 42, Issue 1, 2005, Pages 194-199

  Xue, Xiaochang ^a   Wang, Zenglu ^a   Yan, Zhen ^a   Shi, Jihong ^a   Han, Wei ^a   Zhang, Yingqi ^a  

^a NONE

Author keywords

BLyS; Inclusion body; Purification; rBLyS mutant

Indexed keywords

B CELL ACTIVATING FACTOR; DITHIOTHREITOL; EPITOPE; GUANIDINE; HYBRID PROTEIN; MEMBRANE PROTEIN; RECOMBINANT VACCINE; TETANUS TOXOID; TNFSF13B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SEQUENCE; ARTICLE; BIOSYNTHESIS; CELL INCLUSION; CHEMISTRY; ESCHERICHIA COLI; GEL CHROMATOGRAPHY; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN FOLDING;

AMINO ACID SEQUENCE; B-CELL ACTIVATING FACTOR; CHROMATOGRAPHY, GEL; DITHIOTHREITOL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITOPES, T-LYMPHOCYTE; ESCHERICHIA COLI; GENE EXPRESSION; GUANIDINE; HUMANS; INCLUSION BODIES; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN FOLDING; RECOMBINANT FUSION PROTEINS; TETANUS TOXOID; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, SYNTHETIC;

ESCHERICHIA COLI; MUS MUSCULUS;

EID: 20444412384     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2005.03.032     Document Type: Article

References (27)

1. P.A. Moore, O. Belvedere, A. Orr, K. Pieri, D.W. LaFleur, P. Feng, D. Soppet, M. Charters, R. Gentz, D. Parmelee, Y. Li, O. Galperina, J. Giri, V. Roschke, B. Nardelli, J. Carrell, S. Sosnovtseva, W. Greenfield, S.M. Ruben, H.S. Olsen, J. Fikes, and D.M. Hilbert BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator Science 285 1999 260 263
2. P. Schneider, F. MacKay, V. Steiner, K. Hofmann, J.L. Bodmer, N. Holler, C. Ambrose, P. Lawton, S. Bixler, H. Acha-Orbea, D. Valmori, P. Romero, C. Werner-Favre, R.H. Zubler, J.L. Browning, and J. Tschopp BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth J. Exp. Med. 189 1999 1747 1756
3. A. Mukhopadhyay, J. Ni, Y. Zhai, G.L. Yu, and B.B. Aggarwal Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase J. Biol. Chem. 274 1999 15978 15981
4. H.B. Shu, W.H. Hu, and H. Johnson TALL-1 is a novel member of the TNF family that is down-regulated by mitogens J. Leukoc. Biol. 65 1999 680 683
5. S. Hu, K. Tamada, J. Ni, C. Vincenz, and L. Chen Characterization of TNFRSF19, a novel member of the tumor necrosis factor receptor superfamily Genomics 62 1999 103 107
6. R.M. Locksley, N. Killeen, and M.J. Lenardo The TNF and TNF receptor superfamilies: integrating mammalian biology Cell 104 2001 487 501
7. B.L. Hsu, S.M. Harless, R.C. Lindsley, D.M. Hilbert, and M.P. Cancro Cutting Edge: BLys enables survival of transitional and mature B cells through distinct mediators J. Immunol. 168 2002 5993 5996
8. G.U. von Bulow, and R.J. Bram NF-AT activation induced by a CAML- interacting member of the tumor necrosis factor receptor superfamily Science 278 1997 138 141
9. J.S. Thompson, P. Schneider, S.L. Kalled, L.C. Wang, E.A. Lefevre, T.G. Cachero, F. MacKay, S.A. Bixler, M. Zafari, Z.Y. Liu, S.A. Woodcock, F. Qian, M. Batten, C. Madry, Y. Richard, C.D. Benjamin, J.L. Browning, A. Tsapis, J. Tschopp, and C. Ambrose BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population J. Exp. Med. 192 2000 129 135
10. B. Schiemann, J.L. Gommerman, K. Vora, T.G. Cachero, S. Shulga-Morskaya, M. Dobles, E. Frew, and M.L. Scott An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway Science 293 2001 2111 2114
11. P. Schneider, H. Takatsuka, A. Wilson, F. Mackay, A. Tardivel, S. Lens, T.G. Cachero, D. Finke, F. Beermann, and J. Tschopp Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen J. Exp. Med. 194 2001 1691 1697
12. F. Mackay, S.A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher, P. Schneider, J. Tschopp, and J.L. Browning Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations J. Exp. Med. 190 1999 1697 1710
13. S.D. Khare, I. Sarosi, X.Z. Xia, S. McCabe, K. Miner, I. Solovyev, N. Hawkins, M. Kelley, D. Chang, G. Van, L. Ross, J. Delaney, L. Wang, D. Lacey, W.J. Boyle, and H. Hsu Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice Proc. Natl. Acad. Sci. USA 97 2000 3370 3375
14. J.A. Gross, J. Johnston, S. Mudri, R. Enselman, S.R. Dillon, K. Madden, W. Xu, J. Parrish-Novak, D. Foster, C. Lofton-Day, M. Moore, A. Littau, A. Grossman, H. Haugen, K. Foley, H. Blumberg, K. Harrison, W. Kindsvogel, and C.H. Clegg TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease Nature 404 2000 995 999
15. J. Groom, S.L. Kalled, A.H. Cutler, C. Olson, S.A. Woodcock, P. Schneider, J. Tschopp, T.G. Cachero, M. Batten, J. Wheway, D. Mauri, D. Cavill, T.P. Gordon, C.R. Mackay, and F. Mackay Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome J. Clin. Invest. 109 2002 59 68
16. G.S. Cheema, V. Roschke, D.M. Hilbert, and W. Stohl Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases Arthr. Rheum. 44 2001 1313 1319
17. J. Zhang, V. Roschke, K.P. Baker, Z. Wang, G.S. Alarcon, B.J. Fessler, H. Bastian, R.P. Kimberly, and T. Zhou Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus J. Immunol. 166 2001 6 10
18. I. Dalum, D.M. Butler, M.R. Jensen, P. Hindersson, L. Steinaa, A.M. Waterston, S.N. Grell, M. Feldmann, H.I. Elsner, and S. Mouritsen Therapeutic antibodies elicited by immunization against TNF-alpha Nat. Biotechnol. 17 1999 666 669
19. I. Dalum, M.R. Jensen, P. Hindersson, H.I. Elsner, and S. Mouritsen Breaking of B cell tolerance toward a highly conserved self protein J. Immunol. 157 1996 4796 4804
20. I. Dalum, M.R. Jensen, K. Gregorius, C.M. Thomasen, H.I. Elsner, and S. Mouritsen Induction of cross-reactive antibodies against a self protein by immunization with a modified self protein containing a foreign T helper epitope Mol. Immunol. 34 1997 1113 1120
21. Z. Yu, F. Healy, D. Valmori, P. Escobar, G. Corradin, and J.P. Mach Peptide-antibody conjugates for tumour therapy: a MHC-class-II-restricted tetanus toxin peptide coupled to an anti-Ig light chain antibody can induce cytotoxic lysis of a human B-cell lymphoma by specific CD4 T cells Int. J. Cancer. 56 1994 244 248
22. D. Valmori, A. Pessi, E. Bianchi, and G. Corradin Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination J. Immunol. 149 1992 717 721
23. H. Towbin, T. Staehelin, and J. Gordon Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications Proc. Natl. Acad. Sci. USA 76 1979 4350 4354
24. F.A. Marston, P.A. Lowe, M.T. Doel, J.M. Schoemaker, S. White, and S. Angal Purification of calf prochymosin (prorennin) synthesized in Escherichia coli Biotechnology (NY) 2 1984 800 804
25. M.E. Winkler, M. Blaber, G.L. Bennett, W. Holmes, and G.A. Vehar Purification and characterization of recombinant urokinase from Escherichia coli Biotechnology (NY) 3 1985 990 1000
26. R. Amons, and P.I. Schrier Removal of sodium dodecyl sulfate from proteins and peptides by gel filtration Anal. Biochem. 116 1981 439 443
27. D. Eliana, and C. Bernardez Refolding of recombinant proteins Curr. Opin. Biotechnol. 9 1998 157 163